Skip to content

Company information lookup

ALCHEMIA LIMITED (ACL)

The development of carbohydrate-based molecules for therapeutic applications.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACL 0.620 3.33% 0.620 0.650 0.610 0.650 0.605 270,317

ALCHEMIA LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACL
Securities
Official Listing Date 23 December, 2003
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Registered Office Address Brisbane Technology Park, 3 Hi-Tech Court, Eight Mile Plains, QLD, AUSTRALIA, 4113
Head Office Telephone (07) 3340 0200
Head Office Fax (07) 3340 0200
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 15, 324 QUEEN STREET, BRISBANE, QLD, AUSTRALIA, 4000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Santo Costa (Non Exec. Chairman)
Mr Thomas Liquard (CEO)
Mr Nathan Drona (Non Exec. Director)
Mr Timothy Hughes (Non Exec. Director)
Ms Susan Kelley (Non Exec. Director)
Ms Tracie Ramsdale (Non Exec. Director)
Mrs Jenni Pilcher (CFO)
Company Secretary Mr Stephen Denaro
Principal Activities The development of carbohydrate-based molecules for therapeutic applications.

ALCHEMIA LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
23/10/2014   Tracey Brown 2014 Victorian Telstra Business Woman of the 3 PDF
17/10/2014 asterix Appendix 4C - quarterly 5 PDF
14/10/2014   Notice of Annual Meeting Correction 2 PDF
10/10/2014   Annual Report to shareholders 98 PDF
10/10/2014   Notice of Annual General Meeting/Proxy Form 30 PDF
10/10/2014 asterix Database Lock for HA-Irinotecan Pivotal Phase III Trial 3 PDF
26/09/2014   Appendix 3B 8 PDF
16/09/2014   Appendix 3B 8 PDF
12/09/2014 asterix Update on Phase III Trial of HA-Irinotecan in mCRC 2 PDF
09/09/2014   Change in substantial holding from HHL 5 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
24 Oct 2014 0.620 3.33% 0.650 0.605 270,317
23 Oct 2014 0.600 -1.64% 0.620 0.585 1,584,402
22 Oct 2014 0.610 -3.17% 0.635 0.550 3,043,456
21 Oct 2014 0.630 -3.08% 0.650 0.630 192,614
20 Oct 2014 0.650 -1.52% 0.660 0.640 155,275

* Volume of shares shown represents only those shares traded on ASX.

ALCHEMIA LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ACL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ACL

Warrants & Structured Products

No warrants & Structured Products are available over the security ACL